"I'm excited about this new archery range, because for the longest time, in Metro Manila, there's no public range,” national archery coach Nino Sinco said during the range’s grand opening on Saturday.
With couples, families, and significant others planning date ideas or nights in and out, Philstar.com has listed a number of ...
Close to 140 footbridges have been built in the capital region, with millions spent on each one. But if the Marcos administration wants to put pedestrians first, is a footbridge policy the way to go?
ARIS TOLEDO remained the “Man of Steel” of Philippine athletics with his powerful performance in decathlon and Christine Hallasgo gifted herself a gold medal on Mothers’ Day with a runaway finish in ...
Abalos also cited successful mass transport systems in Hong Kong, Japan, and Thailand that have significantly improved urban ...
14h
Cebu Daily News on MSNSM Seaside Arena not tet in Cesafi’s plans as future playing venueThe anticipation for the upcoming SM Seaside Arena is undeniable, but it seems that the Cebu Schools Athletic Foundation, Inc ...
In a bid to expand its footprint outside Metro Manila, Century Properties Group (CPG) is building a mid-rise residential development at Azure North Estate in San Fernando, ...
17h
The Manila Times on MSNP200 wage hike gets more supportTHE National Anti-Poverty Commission-Formal Labor and Migrant Workers Sectoral Council (NAPC-FLMWSC) has expressed support for the P200 across the board salary increase among private sector workers ...
After recent issues in her personal life, Anthony Jennings’ ex-girlfriend, Jamela Villanueva, reflected on her self-worth, new beginnings and forgiveness.
The trial of impeached Philippine Vice President Sara Duterte cannot be rushed and will only begin in June, the Senate’s president said, while analysts described it as a political numbers game likely ...
Cebu’s dining scene is sizzling. Familiar names from Manila have recently set up shop, with long-established brands, some around for decades in the capital, fin ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results